International
The Morning Science

What science found today

‹
 

Research2 sources

Pluripotent stem cell-derived extracellular vesicles for systemic immune modulation in diabetes therapy

Nature · By Jana Zarubova ·

The Brief · written from 2 sources

  • Two papers published online in Nature Nanotechnology on 18 November 2026 report that pluripotent stem cells secrete extracellular vesicles with unique molecular signatures and immunomodulatory activity.
  • The second paper reports that these vesicles induce immune tolerance and can be produced at scale in suspension culture.
  • The second paper also reports delivery from an injectable hydrogel in the context of diabetes therapy; the source excerpt is cut off before stating the protective outcome.

Why it matters

The work suggests a cell-free approach to immune tolerance that could be relevant to diabetes therapy, and its scalable production and injectable delivery are the practical points for researchers to evaluate.

Who’s affected

  • immunology and diabetes researchers
  • nanomedicine and stem cell researchers

Nature Nanotechnology, Published online: 18 November 2026; doi:10.1038/s41565-026-02320-z Pluripotent stem cells secrete extracellular vesicles that induce immune tolerance and, when produced at scale in suspension culture and delivered from an injectable hydrogel, protect…

Timeline

  1. Two papers published online in Nature Nanotechnology

  2. nature.com

    A pluripotent source of immune tolerance

  3. nature.com

    Pluripotent stem cell-derived extracellular vesicles for systemic immune modulation in diabetes therapy

Full coverage · 2 sources

How do you feel about this?

0 Comments

    Pluripotent stem cell-derived extracellular vesicles for systemic immune modulation in diabetes therapy – The Morning Science